|
"2023 Global Celecoxib Market Share: Future Demand and SWOT Analysis, Forecast 2030", 22 September 2023, INDUSTRY RESEARCH BIZ
|
|
429 LIGHT DIFFRACTION MEASUREMENT OF PARTICLE SIZE, 21 September 2023 (2023-09-21), Retrieved from the Internet <URL:https://www.usp.org/sites/default/files/usp/document/harmonization/gen-chapter/g13_pf_35_3_2009.pdf>
|
|
ALSAAB, H. O.ALHARBI, F. D.ALHIBS, A. S.ALANAZI, N. B.ALSHEHRI, B. Y.SALEH, M. A.ALSHEHRI, F. S.ALGARNI, M. A.ALMUGAITEEB, T.UDDIN: "PLGA-Based Nanomedicine: History of Advancement and Development in Clinical Applications of Multiple Diseases", PHARMACEUTICS, vol. 14, 2022, pages 2728
|
|
AN, F. F.ZHANG, X. H: "Strategies for Preparing Albumin-based Nanoparticles for Multifunctional Bioimaging and Drug Delivery", THERANOSTICS, vol. 7, no. 15, 2017, pages 3667 - 3689, XP055708600, DOI: 10.7150/thno.19365
|
|
AOKI, K; HIRAMATSU, K.; KIMURA, K.; KANESHINA, S.; NAKAMURA, Y.; SATO, K.: "Heat Denaturation of Bovine Serum Albumin. I. Analysis by Acrylamide-gel Electrophoresis", BULL. INST. CHEM. RES., vol. 47, 1969, pages 274 - 282
|
|
BLACK-BOX WARNING ADDED TO CELEBREX LABELING, 20 September 2023 (2023-09-20), Retrieved from the Internet <URL:https://www.fdanews.com/articles/75244-black-box-warning-added-to-celebrex-labeling>
|
|
BROWN, S. B.; WANG, L.; JUNGELS, R. R.; SHARMA, B.: "Effects of cartilage-targeting moieties on nanoparticle biodistribution in healthy and osteoarthritic joints", BIOMATER., vol. 101, 2020, pages 469 - 483
|
|
BRUNO, M. C.CRISTIANO, M. C.CELIA, C.D'AVANZO, N.MANCUSO, A.PAOLINO, D.WOLFRAM, J.FRESTA, M: "Injectable Drug Delivery Systems for Osteoarthritis and Rheumatoid Arthritis", ACS NANO, vol. 16, no. 12, 2022, pages 19665 - 19690
|
|
CDER STATEMENT: FDA APPROVES LABELING SUPPLEMENT FOR CELEBREX (CELECOXIB)., 20 September 2023 (2023-09-20), Retrieved from the Internet <URL:https://www.fda.gov/drugs/drug-safety-and-availability/cder-statement-fda-approves-labeling-supplement-celebrex-celecoxib>
|
|
CELECOXIB | EUROPEAN MEDICINES AGENCY - EUROPEAN UNION, 20 September 2023 (2023-09-20), Retrieved from the Internet <URL:https://www.ema.europa.eu/en/medicines/human/referrals/celecoxib-0#overview-section>
|
|
CHEN, Q.; LIU, X.; CHEN, J.; ZENG, J.; CHENG, Z.; LIU, Z.: "A Self-Assembled Albumin-Based Nanoprobe for In Vivo Ratiometric Photoacoustic pH Imaging", ADV. MATER., vol. 27, no. 43, 2015, pages 6820 - 6827, XP055704265, DOI: 10.1002/adma.201503194
|
|
COKELAERE, S. M.; PLOMP, S. G. M.; DE BOEF, E.; DE LEEUW, M.; BOOL, S.; VAN DE LEST, C. H. A.; VAN WEEREN, P. R.; KORTHAGEN, N. M.: "Sustained intra-articular release of celecoxib in an equine repeated LPS synovitis model", BIOPHARM., vol. 128, 2018, pages 327 - 336
|
|
COX-2 INHIBITORS: WHAT THEY ARE, USES & SIDE EFFECTS, 20 September 2023 (2023-09-20), Retrieved from the Internet <URL:https://my.clevelandclinic.org/health/drugs/23119-cox-2-inhibitors>
|
|
CROFFORD, L. J: "Use of NSAIDs in treating patients with arthritis", ARTHRITIS RES. THER., vol. 15, 2013, pages S2
|
|
DAS, N. K.; GHOSH, N.; KALE, A. P.; MONDAL, R.; ANAND, U.; GHOSH, S.; TIWARI, V. K.; KAPUR, M.; MUKHERJEE, S.: "Temperature induced morphological transitions from native to unfolded aggregated States of human serum albumin", CHEM. B, vol. 118, no. 26, 2014, pages 7267 - 7276
|
|
DONG, J.JIANG, D.WANG, Z.WU, G.MIAO, L.HUANG, L: "Intra-articular delivery of liposomal celecoxib-hyaluronate combination for the treatment of osteoarthritis in rabbit model", INT. J. PHARM, vol. 441, 2013, pages 285 - 290
|
|
EL-GOGARY, R. I.KHATTAB, M. A.ABD-ALLAH, H: "Intra-articular multifunctional celecoxib loaded hyaluronan nanocapsules for the suppression of inflammation in an osteoarthritic rat model", INT. J. PHARM., vol. 583, 2020, pages 119378
|
|
GIKA, H.G.; THEODORIDOUC, A.; MICHOPOULOSA, F.; THEODORIDISA, G.; DIZAD, E.;SETTAS, L.; NIKOLAIDIS, P.; SMITH, C.; WILSONB, I. D.: "Determination of two COX-2 inhibitors in serum and synovial fluid of patients with inflammatory arthritis by ultra performance liquid chromatography-inductively coupled plasma mass spectroscopy and quadrupole time-of-flight mass spectrometry", ANAL., vol. 49, 2009, pages 579 - 586, XP026006056, DOI: 10.1016/j.jpba.2008.12.006
|
|
HONG, S.CHOI, D. W.KIM, H. N.PARK, C. G.LEE, W.PARK, H. H: "Protein-Based Nanoparticles as Drug Delivery Systems", PHARMACEUTICS, vol. 12, 2020, pages 604
|
|
HORNOK, V: "Serum Albumin Nanoparticles: Problems and Prospects", POLYMERS, vol. 13, 2021, pages 3759
|
|
HUANG ET AL., DRUG DELIV., vol. 29, no. 1, December 2022 (2022-12-01), pages 767 - 791
|
|
HUANG, H.LOU, Z.ZHENG, S.WU, J.YAO, Q.CHEN, R.KOU, L.CHEN, D: "Intra-articular drug delivery systems for osteoarthritis therapy: shifting from sustained release to enhancing penetration into cartilage", DRUG DELIV., vol. 29, no. 1, 2022, pages 767 - 791
|
|
IMPURITIES: GUIDELINE FOR RESIDUAL SOLVENTS Q3C(R8), 21 September 2023 (2023-09-21), Retrieved from the Internet <URL:https://database.ich.org/sites/default/files/ICH_Q3C-R8_Guideline_Step4_2021_0422_1.pdf>
|
|
ISHAY, R. B.ISRAEL, L. L.EITAN, E. L.PARTOUCHE, D. M.LELLOUCHE, J. P.: "Maghemite-human serum albumin hybrid nanoparticles: towards a theranostic system with high MRI r(2)* relaxivity", J. MATER. CHEM. B, vol. 4, no. 21, 2016, pages 3801 - 3814
|
|
JAHANBAN-ESFAHLAN, A.PANAHI-AZAR, V: "Interaction of glutathione with bovine serum albumin: Spectroscopy and molecular docking", FOOD CHEM, vol. 202, 2016, pages 426 - 431, XP029440307, DOI: 10.1016/j.foodchem.2016.02.026
|
|
JEVSEVAR, D. S: "J. Am. Acad. Orthop. Surg.", vol. 21, 2013, article "Treatment of osteoarthritis of the knee: evidence-based guideline", pages: 571 - 576
|
|
KHANDELIA, R.; BHANDARI, S.; PAN, U. N.; GHOSH, S. S.; CHATTOPADHYAY, A.: "Gold Nanocluster Embedded Albumin Nanoparticles for Two-Photon Imaging of Cancer Cells Accompanying Drug Delivery", SMALL, vol. 11, no. 33, 2015, pages 4075 - 4081, XP093010109, DOI: 10.1002/smll.201500216
|
|
KOU, L.XIAO, S.SUN, R.BAO, S.YAO, Q.CHEN, R: "Biomaterial-engineered intra-articular drug delivery systems for osteoarthritis therapy", DRUG DELIV, vol. 26, no. 1, 2019, pages 870 - 885
|
|
KOUCHAKZADEH, H.SHOJAOSADATI, S. A.MAGHSOUDI, A.VASHEGHANI FARAHANI, E.: "Optimization of PEGylation conditions for BSA nanoparticles using response surface methodology", AAPS PHARMSCITECH, vol. 11, no. 3, 2010, pages 1206 - 1211, XP055926291, DOI: 10.1208/s12249-010-9487-8
|
|
LEVICK, J. R: "Permeability of rheumatoid and normal human synovium to specific plasma proteins", ARTHRITIS RHEUMATOL, vol. 24, no. 12, 1981, pages 1550 - 1560
|
|
LI, X.; DAI, B.; GUO, J.; ZHENG, L.; GUO, Q.; PENG, J.; XU, J.; QIN, L.: "Nanoparticle-Cartilage Interaction: Pathology-Based Intra-articular Drug Delivery for Osteoarthritis Therapy", NANOMICRO LETT, vol. 13, 2021, pages 149
|
|
LIU, L.HU, F.WANG, H.WU, X.ELTAHAN, A. S.STANFORD, S.BOTTINI, N.XIAO, H.BOTTINI, M.GUO, W. ET AL.: "Secreted Protein Acidic and Rich in Cysteine Mediated Biomimetic Delivery of Methotrexate by Albumin-Based Nanomedicines for Rheumatoid Arthritis Therapy", ACS NANO, vol. 13, no. 5, 2019, pages 5036 - 5048
|
|
LOUKOV, D.KARAMPATOS, S.MALY, M. R.BOWDISH, D.M.E: "Monocyte activation is elevated in women with knee-osteoarthritis and associated with inflammation, BMI and pain", OSTEOARTHR. CARTIL., vol. 26, 2018, pages 255 - 263
|
|
MALIK ET AL., MOL. PHARMACEUTICS, vol. 9, no. 3, 2012, pages 605 - 614, Retrieved from the Internet <URL:https://doi.org/10.1021/mp2005164>
|
|
MITCHELL, M. J.; BILLINGSLEY, M. M.; HALEY, R. M.; WECHSLER, M. E.; PEPPAS, N.A.; LANGER, R.: "Engineering precision nanoparticles for drug delivery", NAT. REV. DRUG DISCOV., vol. 20, no. 2, 2021, pages 101 - 124, XP037357628, DOI: 10.1038/s41573-020-0090-8
|
|
MOHAMMAD-BEIGI, H.SHOJAOSADATI, S. A.MORSHEDI, D.MIRZAZADEH, N.ARPANAEI, A: "The Effects of Organic Solvents on the Physicochemical Properties of Human Serum Albumin Nanoparticles", IRAN J BIOTECH., vol. 14, no. 1, 2016, pages e1168
|
|
NAKAMURA, S.KAMIHAGI, K.SATAKEDA, H.KATAYAMA, M.PAN, H.OKAMOTO, H.NOSHIRO, M.TAKAHASHI, K.YOSHIHARA, Y.SHIMMEI, M.: "Enhancement of SPARC (osteonectin) synthesis in arthritic cartilage. Increased levels in synovial fluids from patients with rheumatoid arthritis and regulation by growth factors and cytokines in chondrocyte cultures", ARTHRITIS RHEUMATOL, vol. 39, no. 4, 1996, pages 539 - 551
|
|
OSTEOARTHRITIS THERAPEUTICS MARKET, 22 September 2023 (2023-09-22), Retrieved from the Internet <URL:https://www.alliedmarketresearch.com/osteoarthritis-treatment-market-A12691>
|
|
PAVANETTO, F.GENTA, I.GIUNCHEDI, P.CONTI, B.CONTE, U: "Spray-dried albumin microspheres for the intra-articular delivery of dexamethasone", J. MICROENCAPSUL., vol. 11, no. 4, 1994, pages 445 - 454, XP000451974
|
|
RATCLIFFE, J. H.HUNNEYBALL, I. M.SMITH, A.WILSON, C. G.DAVIS, S. S: "Preparation and evaluation of biodegradable polymeric systems for the intra-articular delivery of drugs", J. PHARM. PHARMACOL., vol. 36, no. 7, 1984, pages 431 - 436, XP055020751, DOI: 10.1111/j.2042-7158.1984.tb04419.x
|
|
REFERENCESMAUDENS, PJORDAN, 0.;ALLÉMANN, E: "Recent advances in intra-articular drug delivery systems for osteoarthritis therapy", DRUG DISCOV. TODAY, vol. 23, no. 10, 2018, pages 1761 - 1775
|
|
RUBINO, F. M: "Toxicity of Glutathione-Binding Metals: A Review of Targets and Mechanisms", TOXICS, vol. 3, no. 1, 2015, pages 20 - 62, XP055664542, DOI: 10.3390/toxics3010020
|
|
SASIDHARAN, S.; BAHADUR, D.; SRIVASTAVA, R.: "Protein-Poly(amino acid) Nanocore-Shell Mediated Synthesis of Branched Gold Nanostructures for Computed Tomographic Imaging and Photothermal Therapy of Cancer", INTERFACES, vol. 8, no. 25, 2016, pages 15889 - 15903
|
|
SEEDHER, N.; BHATIA, S.: "Reversible binding of celecoxib and valdecoxib with human serum albumin using fluorescence spectroscopic technique", RES., vol. 54, no. 2, 2006, pages 77 - 84, XP024907848, DOI: 10.1016/j.phrs.2006.02.008
|
|
SONG, P.CUI, Z.HU, L: "Applications and prospects of intra-articular drug delivery system in arthritis therapeutics", J. CONTROL. RELEASE, vol. 352, 2022, pages 946 - 960
|
|
SPADA, A.EMAMI, J.TUSZYNSKI, J. A.LAVASANIFAR, A: "The Uniqueness of Albumin as a Carrier in Nanodrug Delivery", MOL. PHARMACEUTICS, vol. 18, no. 5, 2021, pages 1862 - 1894
|
|
STEINHAUSER, I. M.LANGER, K.STREBHARDT, K. M.SPANKUCH, B: "Effect of trastuzumab-modified antisense oligonucleotide-loaded human serum albumin nanoparticles prepared by heat denaturation", BIOMATERIALS, vol. 29, no. 29, 2008, pages 4022 - 4028, XP023611047, DOI: 10.1016/j.biomaterials.2008.07.001
|
|
TELLEGEN, A. R.; RUDNIK-JANSEN, I.; UTOMO, L.; VERSTEEG, S.; BEUKERS, M.;MAARSCHALKERWEERD, R.; VAN ZUILEN, D.; VAN KLAVEREN, N. J: "Sustained release of locally delivered celecoxib provides pain relief for osteoarthritis: a proof of concept in dog patients", OSTEOARTHR. CARTIL., vol. 31, no. 3, 2023, pages 351 - 362
|
|
THAKKAR, H.SHARMA, R. K.MISHRA, A. K.CHUTTANI, K.MURTHY, R. R: "Albumin microspheres as carriers for the antiarthritic drug celecoxib", AAPS PHARMSCITECH, vol. 6, no. 1, 2005, pages E65 - 73
|
|
THAKKAR, H.SHARMA, R. K.MISHRA, A. K.CHUTTANI, K.MURTHY, R. S: "Celecoxib incorporated chitosan microspheres: in vitro and in vivo evaluation", J. DRUG TARGET., vol. 12, no. 9-10, 2004, pages 549 - 557
|
|
THAO LE, Q.BYEON, H. J.LEE, C.LEE, S.LEE, E. S.CHOI, H. G.PARK, E. S.YOUN, Y. S: "Pharmaceutical potential of tacrolimus-loaded albumin nanoparticles having targetability to rheumatoid arthritis tissues", INT. J. PHARM., vol. 497, 2016, pages 268 - 276, XP029373113, DOI: 10.1016/j.ijpharm.2015.12.004
|
|
URBAN, M. K: "COX-2 specific inhibitors offer improved advantages over traditional NSAIDs", ORTHOPEDICS, vol. 23, no. 7, 2000, pages 761 - 764
|
|
WEBER, C.COESTER, C.KREUTER, J.LANGER, K: "Desolvation process and surface characterisation of protein nanoparticles", INT. J. PHARM., vol. 194, no. 1, 2000, pages 91 - 102, XP055421301, DOI: 10.1016/S0378-5173(99)00370-1
|
|
WEST, J. D.; STAMM, C. E.; BROWN, H. A.; JUSTICE, S. L.; MORANO, K. A.: "Enhanced toxicity of the protein cross-linkers divinyl sulfone and diethyl acetylenedicarboxylate in comparison to related monofunctional electrophiles", CHEM. RES. TOXICOL., vol. 24, no. 9, 2011, pages 1457 - 1459
|
|
YAN, F.; LI, H.; ZHONG, Z.; ZHOU, M.; LIN, Y.; TANG, C.; LI, C.: "Co-Delivery of Prednisolone and Curcumin in Human Serum Albumin Nanoparticles for Effective Treatment of Rheumatoid Arthritis", INT. J. NANOMED., vol. 14, 2019, pages 9113 - 9125
|
|
YAN, H.; DUAN, X.; PAN, H.; HOLGUIN, N.; RAI, M. F.; AKK, A.; SPRINGER, L. E.;WICKLINE, S. A.; SANDELL, L. J.; PHAM, C. T.: "Suppression of NF-xB activity via nanoparticle-based siRNA delivery alters early cartilage responses to injury", NATL. ACAD. SCI. U.S.A., vol. 113, no. 41, 2016, pages E6199 - E6208
|
|
ZAYED, M. A.; HAWASH, M. F.; FAHMEY, M. A.; EL-GIZOULI, A. M. M.: "Investigation of ibuprofen drug using mass spectrometry, thermal analyses, and semi-empirical molecular orbital calculation", J. THERM. ANAL. CALORIM., vol. 108, 2012, pages 315 - 322, XP035024234, DOI: 10.1007/s10973-011-1876-z
|
|
ZETA POTENTIAL - AN INTRODUCTION IN 30 MINUTES, 21 September 2023 (2023-09-21), Retrieved from the Internet <URL:https://www.malvernpanalytical.com/en/learn/knowledge-center/technical-notes/tn101104zetapotentialintroduction>
|
|
ZHANG, S.CHO, W. J.JIN, A. T.KOK, L. Y.SHI, Y.HELLER, D. E.LEE, Y. L.ZHOU, Y.XIE, X.KORZENIK, J. R. ET AL.: "Heparin-Coated Albumin Nanoparticles for Drug Combination in Targeting Inflamed Intestine", ADV. HEALTHC. MATER., vol. 9, no. 16, 2020, pages e2000536
|
|
ZHENG, X.YU, X.WANG, C.LIU, Y.JIA, M.LEI, F.TIAN, J.LI, C: "Targeted co-delivery biomimetic nanoparticles reverse macrophage polarization for enhanced rheumatoid arthritis therapy", DRUG DELIV, vol. 29, no. 1, 2022, pages 1025 - 1037
|
|
ZILRETTA PRODUCT, 21 September 2023 (2023-09-21), Retrieved from the Internet <URL:https://www.pacira.com/products/zilretta>
|